Activation or suppression of NFκB by HPK1 determines sensitivity to activation-induced cell death

被引:64
作者
Brenner, D
Golks, A
Kiefer, F
Krammer, PH
Arnold, R
机构
[1] German Canc Res Ctr, Tumor Immunol Program, D-69112 Heidelberg, Germany
[2] Max Planck Inst Mol Biomed, Munster, Germany
关键词
AICD; apoptosis; IKK; signaling; TCR;
D O I
10.1038/sj.emboj.7600894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Restimulation of the T-cell receptor (TCR) in activated T cells induces CD95 (Fas/Apo-1)-mediated activation-induced cell death (AICD). The TCR-proximal mechanisms leading to AICD are elusive. Here we characterize hematopoietic progenitor kinase 1 (HPK1) as a differentially regulated TCR-proximal signaling protein involved in AICD of primary T cells. We show that HPK1 is a functional component of the endogenous I kappa B kinase (IKK) complex and is crucial for TCR-mediated NF kappa B activation. While full-length HPK1 enhances IKK beta phosphorylation, siRNA-mediated knockdown of HPK1 blunts TCR-mediated NF kappa B activation and increases cell death. We also demonstrate proteolytic processing of HPK1 into HPK1-C, specifically in AICD-sensitive primary T cells. The cleavage product HPK1-C sequesters the inactive IKK complex and suppresses NF kappa B upon TCR restimulation by binding to IKK alpha and IKK beta. T cells of HPK1-C transgenic mice are sensitized towards TCR-mediated AICD. Consequently, preventing HPK1-C generation in primary T cells by siRNA-mediated knockdown results in decreased AICD. Thus, these results show a novel mechanism of sensitization of T lymphocytes towards AICD by suppression of NF kappa B, and propose that HPK1 is a life/death switch in T lymphocytes.
引用
收藏
页码:4279 / 4290
页数:12
相关论文
共 58 条
[1]   Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1 [J].
Arnold, R ;
Patzak, IM ;
Neuhaus, B ;
Vancauwenbergh, S ;
Veillette, A ;
Van Lint, J ;
Kiefer, F .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) :2364-2383
[2]   Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFκB into an inhibitor of NFκB [J].
Arnold, R ;
Liou, J ;
Drexler, HCA ;
Weiss, A ;
Kiefer, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14675-14684
[3]   Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer [J].
Baumann, S ;
Dostert, A ;
Novac, N ;
Bauer, A ;
Schmid, W ;
Fas, SC ;
Krueger, A ;
Heinzel, T ;
Kirchhoff, S ;
Schütz, G ;
Krammer, PH .
BLOOD, 2005, 106 (02) :617-625
[4]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[5]   Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB [J].
Campbell, KJ ;
Rocha, S ;
Perkins, ND .
MOLECULAR CELL, 2004, 13 (06) :853-865
[6]   MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation [J].
Che, TJ ;
You, Y ;
Wang, DH ;
Tanner, MJ ;
Dixit, VM ;
Lin, X .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :15870-15876
[7]   NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ [J].
Coudronniere, N ;
Villalba, M ;
Englund, N ;
Altman, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3394-3399
[8]   Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation [J].
Delhase, M ;
Hayakawa, M ;
Chen, Y ;
Karin, M .
SCIENCE, 1999, 284 (5412) :309-313
[9]   AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].
DHEIN, J ;
WALCZAK, H ;
BAUMLER, C ;
DEBATIN, KM ;
KRAMMER, PH .
NATURE, 1995, 373 (6513) :438-441
[10]   CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation [J].
Gaide, O ;
Favier, B ;
Legler, DF ;
Bonnet, D ;
Brissoni, B ;
Valitutti, S ;
Bron, C ;
Tschopp, J ;
Thome, M .
NATURE IMMUNOLOGY, 2002, 3 (09) :836-843